Zealand Pharma Cash per Share vs. Market Capitalization

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>ZP</div>
ZEAL -- Denmark Stock  

DKK 264.00  12.00  4.76%

The Drivers Module shows relationships between Zealand Pharma's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Zealand Pharma AS over time as well as its relative position and ranking within its peers. Check out Your Current Watchlist

Search Current Fundamental Trends

 
Refresh
Sales per Share is projected to rize to 1.46 this yearZealand Pharma Operating Income is quite stable at the moment as compared to the last year. The company current value of Operating Income is estimated at about 633.51 Million. Net Income Per Employee is projected to rize to about 3.8 M this year, although the value of Net Income will most likely fall to (508.2 M).

Zealand Pharma AS Market Capitalization vs. Cash per Share Fundamental Analysis

Zealand Pharma AS is rated second in cash per share category among related companies. It is rated second in market capitalization category among related companies creating about  207,840,408  of Market Capitalization per Cash per Share.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Zealand Pharma 
Cash per Share 
 = 
Total Cash 
Average Shares 
=
43.11 
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Zealand Pharma 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
=
8.96 B
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Zealand Pharma AS is rated second in market capitalization category among related companies. Market capitalization of Biotechnology industry is at this time estimated at about 17.92 Billion. Zealand Pharma totals roughly 8.96 Billion in market capitalization claiming about 50% of stocks in Biotechnology industry.
Capitalization  Valuation  Revenue  Workforce  Total debt

Zealand Fundamental Comparison

Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page